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Background
It is thought that the interaction of genetic and environ-
mental factors is an important risk factor for Parkinson’s
disease (PD). a-Synuclein (a-syn) is a protein of special
interest in PD because mutations in a-syn (A53T or
A30P or E46K) lead to PD. Manganese (Mn) is a heavy
metal known to cause parkinsonian symptoms. There-
fore, we investigate the effect of manganese (Mn) on
human a-syn-expressing mice.
Materials and methods
C57/Bl6 mice expressing either human a-syn or the
A53T/A30P doubly mutated human a-syn under the
tyrosine hydroxylase promoter and nontransgenic sis-
ter mice were exposed at the age of 4 month to either
MnCl2 (1%) enriched or control food. Locomotor
activity was quantified every 2 months using auto-
mated activity chambers. Mice were sacrificed at the
age of 7 or 20 months. Tyrosine hydroxylase positive
cells in the substantia nigra pars compacta were
quantified in a blinded manner. Neurochemical analy-
sis of neurotransmitters and amino acids was per-
formed in the striatum using high performance liquid
chromatography.
Results
Mobility was increased by Mn, no significant difference
due to the transgenes could be found. Striatal Mn con-
tent was significantly increased about threefold. Quanti-
fication of dopaminergic cell si nt h es u b s t a n t i an i g r a
pars compacta showed a significant cell loss in aged
mice (−10%) but no effect of Mn or transgenes (3-way
ANOVA with factors gene, Mn and age). In 7 months
old mice, neurochemical analysis showed interactions
between transgene and Mn exposure for the ratio
homovanillic acid : dopamine as well as aspartate (2-way
ANOVA with factors gene and Mn). These values were
increased in human a-syn-expressing compared to non-
transgenic mice which were control-fed (17 and 11%,
respectively). There was no increase when animals
obtained Mn-enriched food. Contrary, mutated a-syn-
expressing mice showed an increase compared to non-
transgenic and human a-syn-expressing mice only when
they obtained Mn-enriched food. Analysis of the same
parameters in the 20 months old mice did not reveal
any significant changes.
Conclusions
Under our experimental conditions, Mn and a-syn,
wild-type and doubly mutated, did not induce signs of
neurodegeneration, neither separately nor in interaction.
However, Mn interferes with the dopamine system
through human a-syn: manganese exposure decreased
DA turnover in the striatum of mice expressing human
a-syn wild-type. This effect was lost by the two parkin-
sonism inducing mutations.
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